Flunixin Meglumine Injection
Fort Dodge Animal Health announces the U.S. Food and Drug Administration (FDA) approved the use of Flunixamine? (flunixin meglumine injection) in lactating dairy cows.
Fort Dodge Animal Health announces the U.S. Food and Drug Administration (FDA) approved the use of Flunixamine® (flunixin meglumine injection) in lactating dairy cows. Flunixamine provides producers with a safe and effective support therapy to control fever associated with Bovine Respiratory Disease (BRD) and fever and inflammation associated with endotoxemia, which are potentially deadly health issues for dairy cattle, the company says.
The clinical signs associated with BRD and endotoxemia are potentially debilitating and may result in severe stress, which in turn hinders the dairy cow's ability to fight infection and efficiently produce high-quality milk.
Flunixamine provides relief by reducing pyrexia associated with BRD and endotoxemia and helps control inflammation caused by endotoxemia. Flunixamine has a 36-hour milk withdrawal and four-day meat withdrawal in lactating dairy cows and heifers.
Flunixamine is available to dairy producers through veterinarians.
For fastest response, call
(800) 533-8536
